1. Home
  2. GDHG vs CVKD Comparison

GDHG vs CVKD Comparison

Compare GDHG & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Golden Heaven Group Holdings Ltd.

GDHG

Golden Heaven Group Holdings Ltd.

N/A

Current Price

$2.69

Market Cap

10.1M

ML Signal

N/A

Logo Cadrenal Therapeutics Inc.

CVKD

Cadrenal Therapeutics Inc.

N/A

Current Price

$7.56

Market Cap

20.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GDHG
CVKD
Founded
2008
2022
Country
China
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
20.7M
IPO Year
2023
2023

Fundamental Metrics

Financial Performance
Metric
GDHG
CVKD
Price
$2.69
$7.56
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$32.00
AVG Volume (30 Days)
12.1K
78.1K
Earning Date
07-11-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,666,899.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.40
$6.76
52 Week High
$1,968.41
$22.90

Technical Indicators

Market Signals
Indicator
GDHG
CVKD
Relative Strength Index (RSI) 27.81 35.40
Support Level $2.52 $6.76
Resistance Level $3.08 $12.50
Average True Range (ATR) 0.39 1.07
MACD -0.03 -0.24
Stochastic Oscillator 8.52 9.41

Price Performance

Historical Comparison
GDHG
CVKD

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: